Condition: Treatment Resistant Hypertension · Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
The goal of this randomized, double-blind, placebo-controlled study is to assess whether the food supplement Endocalyx lowers blood pressure in patients with treatment resistant hypertension.
This description comes directly from the study's public registry record.
Rik Olde Engberink, MD PhD · 0031205661930 · r.h.oldeengberink@amsterdamumc.nl
Sanédy Simon, MD · 0031205667789 · s.s.a.simon@amsterdamumc.nl
Always discuss trial participation with your own doctor first.
| Amsterdam UMC | Amsterdam, North Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06940011